A client is in the post-anesthesia care unit (PACU) following an open abdominal surgery under general anesthesia utilizing desflurane and succinylcholine. The nurse notes new-onset masseter muscle rigidity, tachycardia of , tachypnea, and an end-tidal carbon dioxide () level of . The client's temperature is rapidly rising. Based on these findings, which of the following pharmacological and parenteral interventions should the nurse anticipate implementing? (Select all that apply)
- AReconstitute intravenous dantrolene sodium using sterile water containing a bacteriostatic preservative.
- Hyperventilate the client with oxygen using a bag-valve-mask or through the endotracheal tube.Cevap
- CAdminister intravenous diltiazem to manage the client's sustained tachycardia.
- Initiate a rapid intravenous infusion of chilled sodium chloride.Cevap
- Administer intravenous regular insulin concurrent with dextrose.Cevap
- FAdminister a subsequent dose of intravenous succinylcholine to overcome the masseter muscle rigidity.
Cevap
The nurse should hyperventilate the client with 100% oxygen, initiate a rapid intravenous infusion of chilled 0.9% sodium chloride, and administer intravenous regular insulin concurrent with 50% dextrose.
Malignant hyperthermia is a severe hypermetabolic state. The correct interventions address the critical pathophysiological changes: oxygen flushes out the massive amounts of carbon dioxide produced; chilled intravenous normal saline provides active core cooling; and the combination of regular insulin and dextrose drives extracellular potassium back into the cells, treating the life-threatening hyperkalemia caused by continuous muscle rigidity and breakdown.
Adım Adım Çözüm
Anahtar Kavram
Malignant hyperthermia is a life-threatening pharmacogenetic hypermetabolic crisis triggered by volatile anesthetics and succinylcholine, requiring immediate discontinuation of triggers, administration of dantrolene, oxygenation, active cooling, and management of hyperkalemia.